Condensed Consolidated Statements of Operations - USD ($) |
3 Months Ended | 6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|||||
| Consolidated Statements of Operations [Abstract] | ||||||||
| Net sales | $ 883,300 | $ 836,900 | $ 1,704,500 | $ 1,607,400 | ||||
| Operating costs and expenses(1) | ||||||||
| Cost of revenue | 342,900 | 36,200 | 679,600 | 129,600 | ||||
| Research and development | [1] | 13,041,000 | 4,861,600 | 25,605,900 | 38,020,200 | |||
| Sales and marketing | 556,000 | 1,175,300 | 1,053,400 | 2,245,700 | ||||
| General and administration | [1] | 28,617,900 | 13,418,600 | 53,795,900 | 78,213,700 | |||
| Depreciation and amortization | 1,833,500 | 3,700 | 3,612,700 | 9,300 | ||||
| Total operating costs and expenses | [1] | 44,391,300 | 19,495,400 | 84,747,500 | 118,618,500 | |||
| Loss from operations | (43,508,000) | (18,658,500) | (83,043,000) | (117,011,100) | ||||
| Interest income | 16,836,500 | 2,132,700 | 24,831,700 | 2,161,500 | ||||
| Interest expense | (4,105,100) | 157,800 | (4,291,900) | (2,659,800) | ||||
| Investment income | 11,085,000 | 0 | 11,085,000 | 0 | ||||
| Change in fair value of derivative liabilities | 0 | 0 | 0 | (225,916,000) | ||||
| Loss on the conversion of convertible debt | 0 | 0 | 0 | (542,300) | ||||
| Loss from operations before income taxes | (19,691,600) | (16,368,000) | (51,418,200) | (343,967,700) | ||||
| Income tax expense | (310,300) | 0 | (310,300) | 0 | ||||
| Net loss | (20,001,900) | (16,368,000) | (51,728,500) | (343,967,700) | ||||
| Less net loss attributable to noncontrolling interest | 19,600 | 0 | 19,600 | 0 | ||||
| Net loss available to common stockholders | $ (19,982,300) | $ (16,368,000) | $ (51,708,900) | $ (343,967,700) | ||||
| Loss per share attributable to common stockholders: | ||||||||
| Basic (in Dollars per share) | $ (0.08) | $ (0.1) | $ (0.22) | $ (2.67) | ||||
| Diluted (in Dollars per share) | [2] | $ (0.08) | $ (0.1) | $ (0.22) | $ (2.67) | |||
| Weighted Average Shares used to compute net loss per share attributable to common stockholders: | ||||||||
| Basic (in Shares) | 240,512,552 | 166,726,512 | 230,597,689 | 128,735,253 | ||||
| Diluted (in Shares) | 240,512,552 | 166,726,512 | 230,597,689 | 128,735,253 | ||||
| ||||||||
| X | ||||||||||
- Definition The amount of investment income from option premium and trading securities. No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|